Injective (INJ) Rebounds 18% From Triple-Tested Trendline

Injective's native token, INJ, has rebounded roughly 18% from a trendline that has been tested three times, according to a November 9 report from COINOTAG. In technical analysis, a trendline that holds through repeated tests is among the most closely watched structures on a chart, since each successful defense tends to add to the number of traders tracking it as a reference level.

Market data cited in the report shows INJ trading at $8.117 on November 8, a gain of 14.6% over the previous seven days. The token sits within approximately 8% of a resistance level at $8.75.

According to the report's conditional framing, a daily close above $8.75 would put Injective's October high of $9.417 back in play — a level roughly 16% above where the token stood on November 8. The emphasis on a daily close reflects standard chart-analysis practice, in which the closing price is used to confirm that a level has been cleared rather than only touched during intraday trading, making the $8.75 line and the October high the reference points the report sets out for readers to follow.

About Injective

Injective is a layer-1 blockchain built with the Cosmos SDK, designed for decentralized finance applications including exchange and derivatives infrastructure. The Cosmos SDK is a widely used framework for building application-specific blockchains, a design approach in which networks are tailored to a focused set of workloads rather than general-purpose execution. Its native token, INJ, is used for network governance and staking, and the network incorporates a fee-burn mechanism that reduces token supply — a supply design also adopted by several other exchanges and blockchain networks to tie token issuance to network activity. The project was incubated by Binance and its token launched via the Binance Launchpad in October 2020.

This content was first published on COINOTAG: https://en.coinotag.com/injective-inj-rebounds-18-triple-tested-trendline